PPARγ2 NUCLEAR RECEPTOR CONTROLS MULTIPLE REGULATORY PATHWAYS OF OSTEOBLAST DIFFERENTIATION FROM MARROW MESENCHYMAL STEM CELLS

Rosiglitazone (Rosi), a member of the thiazolidinedione class of drugs used to treat type 2 diabetes, activates the adipocyte-specific transcription factor peroxisome proliferator-activated receptor gamma (PPARγ). This activation causes bone loss in animals and humans, at least in part due to suppre...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Shockley, Keith R., Lazarenko, Oxana P., Czernik, Piotr J., Rosen, Clifford J., Churchill, Gary A., Lecka-Czernik, Beata
Format: Artigo
Sprog:Inglês
Udgivet: 2009
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2745312/
https://ncbi.nlm.nih.gov/pubmed/19115254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.21994
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker